Furthermore, a recent study reported overexpression of TET1 in T-cell acute lymphoblastic leukemia (T-ALL) and TET1-mediated promotion of leukemic growth to be dependent upon its catalytic ability to produce 5hmC (23), supporting the hypothesis that the DNA demethylation pathway represents an avenue for therapeutic action. Here, TET1 is linked to T-cell acute lymphoblastic leukemia.